Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT01401192
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed nonsquamous NSCLC
* Stage IIIb, IV or recurrent NSCLC
* Age ≥ 18years
* ECOG performance status of 0 to 1
* Known TS immunohistochemical analysis data
* At least one measurable lesion by RECIST 1.1
* No previous chemotherapy or therapy with EGFR TKIs for advanced NSCLC
* Asymptomatic brain metastasis or symptomatic brain metastasis treated with local treatment such as operation, whole brain radiotherapy, or gamma-knife surgery
* At least 2 weeks later after whole brain radiotherapy or palliative radiotherapy
* Adequate renal function: estimated creatinine clearance ≥ 50mL/min
Exclusion Criteria:
* Patients whose disease recurred within 6 months after the completion of adjuvant chemotherapy.
* Patients with post-obstructive pneumonia or uncontrolled serious infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01401192
Study Brief:
Protocol Section:
NCT01401192